[ZNF217 is a marker of poor prognosis in breast cancer that drives epithelial-mesenchymal transition and invasion.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE